PCM
KITE

Pentwater Capital Management’s Kite Pharma, Inc. KITE Stock Holding History

Pentwater Capital Management’s Portfolio KITE Stock Details KITE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-290,000
Closed -$52.1M – 122
2017
Q3 		$52.1M Buy
+290,000
New +$40.4M 0.45% 34

Pentwater Capital Management's KITE Position: Q4 2017 in Review

Pentwater Capital Management sold out of Kite Pharma, Inc. (KITE) in Q4 2017, closing a stake of 290,000 shares — an estimated $52.1M sold.

Pentwater Capital Management first reported a position in KITE in Q3 2017 and held it in 1 quarter. The position peaked at $52.1M in Q3 2017. 0 funds tracked by Wall St. Rank hold KITE as of Q4 2017.

  • Pentwater Capital Management reported no remaining Kite Pharma, Inc. position as of Q4 2017 after selling out during the quarter.
  • Pentwater Capital Management sold 290,000 Kite Pharma, Inc. shares in Q4 2017, an estimated $52.1M.
  • Pentwater Capital Management first reported a position in Kite Pharma, Inc. in Q3 2017 and held it in 1 quarter.
  • Pentwater Capital Management's Kite Pharma, Inc. position peaked at $52.1M in Q3 2017.
  • 0 funds tracked by Wall St. Rank held Kite Pharma, Inc. as of Q4 2017.

Based on Pentwater Capital Management's 13F filing for Q4 2017, filed 7 Feb 2018.